The reclassification of marijuana as a schedule III drug continues to move closer. The DEA continues to push to reclassify marijuana as a less dangerous drug.
Looking to round out your portfolio with cool stock options? Consider these currently undervalued cannabis stocks.
IM Cannabis Corp. IMCC, a leading medical marijuana company announced that its common shares are trading on a 6:1 post-consolidated basis.
C21 Investments CXXI and Vext Science VEXT have demonstrated notable financial performance, particularly in cash flow and credit stability. This is significant given the challenges faced by many larger cannabis companies.
On July 10, Zuanic & Associates hosted a panel discussion focusing on the European cannabis market, featuring Benna Goldenberg, CEO of Organigram Holdings OGI, and Finn Age Hansel, CEO of Sanity Group.
Investors are increasingly turning their attention to the booming US cannabis industry. The market is projected to reach $41.5 billion by 2025, reflecting a robust annual growth rate. Recent news about potential federal legalization has further fueled optimism. States like New York and New Jersey have recently legalized recreational use, adding momentum to the industry's expansion. As a result, marijuana stocks are gaining traction. This week, certain companies are standing out as potential winners. Investors should use technical analysis and proper risk management to navigate this volatile market. These tools help in making informed decisions and minimizing potential losses.
As regulations gradually turn friendlier, the global cannabis market is at an inflection point of growth. By the end of the decade, there are likely to be several massive wealth creators among cannabis stocks.
Whatever your opinions on cannabis use might be, it seems as if the current administration has begun to soften the position of federally regulated cannabis. While several states have already legalized the drug for both medical and recreational use, its federal regulation has stood in the way of several high-potential cannabis stocks.
There's a good number of catalysts for cannabis stocks to buy. We already know 88% of Americans want legalization, which the current candidates should use to their advantage for votes.
In the last five years, cannabis stocks have gone through small phases of euphoria that has been followed by a deep correction. There are two major challenges that have kept cannabis stocks depressed.
Back in May, cannabis stocks briefly came back into vogue. This was due to a small amount of regulatory progress.
The cannabis space has been buzzing of late, which makes it ideal to consider exposure to the best cannabis stocks. Germany recently hopped aboard the cannabis legalization train, joining a growing list of countries that embraced both the use and sale of cannabis.